Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Day One Biopharmaceuticals, Inc. (DAWN) had Weighted-Average Shares Outstanding (Basic) of 79.77M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-188.92M |
|
-- |
|
-- |
|
$206.06M |
|
$-206.06M |
|
$17.15M |
|
$-188.92M |
|
$-188.92M |
|
$-188.92M |
|
$-188.92M |
|
$-188.92M |
|
$-188.92M |
|
$-206.06M |
|
$-205.68M |
|
|
Weighted-Average Shares Outstanding (Basic) |
79.77M |
79.77M |
|
$-2.37 |
|
$-2.37 |
|
| Balance Sheet Financials | |
$375.27M |
|
$0.21M |
|
$0.77M |
|
$376.05M |
|
$29.51M |
|
-- |
|
-- |
|
$29.51M |
|
$346.54M |
|
$346.54M |
|
$346.54M |
|
87.23M |
|
| Cash Flow Statement Financials | |
$-146.85M |
|
$128.38M |
|
$164.00M |
|
$85.26M |
|
$230.78M |
|
$145.52M |
|
$39.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-147.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.52% |
|
-54.52% |
|
-50.24% |
|
-54.52% |
|
$3.97 |
|
$-1.84 |
|
$-1.84 |
|